Safety and efficacy of esaxerenone in Japanese hypertensive patients with heart failure with reduced ejection fraction: A retrospective study
Esaxerenone, a mineralocorticoid receptor blocker (MRB), is a new antihypertensive agent. However, esaxerenone-related data with respect to hypertension with heart failure are limited. We investigated the safety and efficacy of esaxerenone in hypertensive patients with heart failure with reduced eje...
Guardado en:
Autores principales: | Togo Iwahana, Yuichi Saito, Sho Okada, Hirotoshi Kato, Ryohei Ono, Yoshio Kobayashi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/87bb5b7e718f4b128a5a68098dd10f26 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and efficacy of esaxerenone in Japanese hypertensive patients with heart failure with reduced ejection fraction: A retrospective study.
por: Togo Iwahana, et al.
Publicado: (2021) -
Literature reviews of stroke with hypereosinophilic syndrome
por: Ryohei Ono, et al.
Publicado: (2021) -
Association between early intensive care or coronary care unit admission and post-discharge performance of activities of daily living in patients with acute decompensated heart failure.
por: Masato Kanda, et al.
Publicado: (2021) -
Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
por: M. A. Manukyan, et al.
Publicado: (2021) -
A study of association between heart failure with preserved ejection fraction with hypertension and diabetes mellitus
por: Swapan Sarkar, et al.
Publicado: (2021)